Sales reported at Rs 3.37 crore
Net loss of Parmax Pharma reported to Rs 0.11 crore in the quarter ended September 2017. There were no net profit/loss reported during the previous quarter ended September 2016. Sales reported to Rs 3.37 crore in the quarter ended September 2017. There were no Sales reported during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales3.370 0 OPM %5.340 -PBDT0.160 0 PBT-0.110 0 NP-0.110 0Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
